MASI
Masimo Corporation NASDAQ Listed Aug 8, 2007$178.47
After hrs
$178.31
+0.00%
Mkt Cap $9.3B
52w Low $125.94
99.0% of range
52w High $179.00
50d MA $177.40
200d MA $153.06
P/E (TTM)
-63.1x
EV/EBITDA
21.0x
P/B
13.3x
Debt/Equity
0.8x
ROE
-21.0%
P/FCF
34.5x
RSI (14)
—
ATR (14)
—
Beta
1.20
50d MA
$177.40
200d MA
$153.06
Avg Volume
1.6M
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. It offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. It offers connectivity devices; and nasal high flow ventilation and neuromodulation solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. The company was incorporated in 1989 and is headquartered in Irvine, California.
52 Discovery · Irvine, CA 92618 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | AMC | 1.41 | 1.10 | -22.0% | 178.58 | -0.0% | -0.1% | -0.0% | — | — | — | — |
| Feb 26, 2026 | AMC | 1.48 | 0.18 | -87.8% | 175.22 | +0.0% | +0.1% | +0.1% | +0.1% | +0.1% | +0.1% | — |
| Nov 4, 2025 | AMC | 1.19 | 1.32 | +10.9% | 149.01 | +1.3% | -4.6% | -3.5% | -3.9% | -3.0% | -1.6% | — |
| Aug 5, 2025 | AMC | 1.23 | 1.33 | +8.1% | 163.88 | -0.5% | -11.7% | -11.6% | -11.7% | -10.1% | -8.4% | — |
| May 6, 2025 | AMC | 1.24 | 1.36 | +9.7% | 161.47 | -11.1% | -7.0% | -4.9% | -3.0% | +1.3% | +0.1% | — |
| Feb 25, 2025 | AMC | 1.42 | 1.80 | +26.8% | 169.54 | +11.2% | +12.3% | +9.8% | +11.3% | +12.4% | +8.2% | — |
| Nov 5, 2024 | AMC | 0.84 | 0.98 | +17.1% | 151.56 | +14.7% | +10.6% | +6.5% | +7.2% | +6.6% | +6.1% | — |
| Aug 6, 2024 | AMC | 0.77 | 0.86 | +11.7% | 110.32 | +7.5% | +11.3% | +16.0% | +15.0% | +15.8% | +16.4% | — |
| May 7, 2024 | AMC | 0.71 | 0.77 | +8.5% | 136.00 | -4.4% | -11.8% | -8.7% | -10.5% | -14.6% | -15.3% | — |
| Feb 27, 2024 | AMC | 0.95 | 1.25 | +31.6% | 130.10 | -4.7% | -1.1% | -1.2% | -2.8% | -2.5% | -0.4% | — |
| Nov 7, 2023 | AMC | 0.59 | 0.63 | +6.8% | 80.60 | -3.0% | +3.7% | +5.3% | +7.9% | +9.5% | +10.6% | — |
| Aug 8, 2023 | AMC | 0.86 | 0.62 | -27.9% | 120.00 | -1.7% | -1.7% | -4.9% | -5.3% | -6.0% | -7.7% | — |
| May 9, 2023 | AMC | 0.83 | 0.87 | +4.8% | 184.25 | -4.6% | -5.3% | -6.2% | -6.3% | -5.9% | -7.5% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 27 | Raymond James | Downgrade | Outperform → Market Perform | — | $176.89 | $176.76 | -0.1% | +0.1% | +0.2% | +0.6% | +0.6% | +1.0% |
| Feb 18 | Wells Fargo | Downgrade | Overweight → Equal Weight | — | $174.69 | $174.80 | +0.1% | +0.5% | +0.4% | +0.2% | +0.3% | +0.4% |
| Feb 18 | BTIG | Downgrade | Buy → Neutral | — | $174.69 | $174.80 | +0.1% | +0.5% | +0.4% | +0.2% | +0.3% | +0.4% |
| Dec 4 | BTIG | Maintains | Buy → Buy | — | $138.09 | $138.27 | +0.1% | +3.0% | +2.6% | +2.0% | +0.4% | +1.2% |
| Nov 24 | BTIG | Maintains | Buy → Buy | — | $149.25 | $149.45 | +0.1% | -2.4% | -1.8% | -3.5% | -4.6% | -3.5% |
| Nov 5 | Wells Fargo | Maintains | Overweight → Overweight | — | $149.01 | $150.98 | +1.3% | -4.6% | -3.5% | -3.9% | -3.0% | -1.6% |
| Nov 5 | BTIG | Maintains | Buy → Buy | — | $149.01 | $150.98 | +1.3% | -4.6% | -3.5% | -3.9% | -3.0% | -1.6% |
| Sep 11 | BTIG | Maintains | Buy → Buy | — | $145.82 | $148.05 | +1.5% | +0.3% | +1.1% | -0.1% | -1.9% | -3.1% |
| Aug 6 | Piper Sandler | Maintains | Overweight → Overweight | — | $163.88 | $162.98 | -0.5% | -11.7% | -11.6% | -11.7% | -10.1% | -8.4% |
| May 7 | Wells Fargo | Maintains | Overweight → Overweight | — | $161.47 | $143.57 | -11.1% | -7.0% | -4.9% | -3.0% | +1.3% | +0.1% |
| May 7 | Raymond James | Maintains | Outperform → Outperform | — | $161.47 | $143.57 | -11.1% | -7.0% | -4.9% | -3.0% | +1.3% | +0.1% |
| May 7 | Piper Sandler | Maintains | Overweight → Overweight | — | $161.47 | $143.57 | -11.1% | -7.0% | -4.9% | -3.0% | +1.3% | +0.1% |
| Apr 10 | Needham | Maintains | Hold → Hold | — | $164.57 | $158.55 | -3.7% | -7.9% | -6.5% | -6.7% | -7.6% | -7.8% |
| Feb 26 | Wells Fargo | Maintains | Overweight → Overweight | — | $169.54 | $188.60 | +11.2% | +12.3% | +9.8% | +11.3% | +12.4% | +8.2% |
| Feb 26 | Needham | Maintains | Hold → Hold | — | $169.54 | $188.60 | +11.2% | +12.3% | +9.8% | +11.3% | +12.4% | +8.2% |
| Feb 26 | Piper Sandler | Maintains | Overweight → Overweight | — | $169.54 | $188.60 | +11.2% | +12.3% | +9.8% | +11.3% | +12.4% | +8.2% |
| Jan 22 | Needham | Maintains | Hold → Hold | — | $176.07 | $176.18 | +0.1% | -1.7% | -4.5% | -3.3% | -3.1% | -0.5% |
| Jan 16 | Needham | Maintains | Hold → Hold | — | $172.07 | $172.00 | -0.0% | -1.2% | +0.1% | +2.3% | +0.6% | -2.3% |
| Dec 27 | Raymond James | Maintains | Outperform → Outperform | — | $171.02 | $170.37 | -0.4% | -0.0% | -1.4% | -3.3% | -1.4% | +0.1% |
| Dec 18 | Piper Sandler | Maintains | Overweight → Overweight | — | $174.07 | $176.47 | +1.4% | -2.0% | -2.3% | -2.6% | -3.8% | -3.3% |
| Dec 11 | Wells Fargo | Maintains | Overweight → Overweight | — | $174.65 | $175.94 | +0.7% | -0.2% | +0.2% | +0.9% | +1.5% | -0.3% |
| Nov 22 | Stifel | Maintains | Buy → Buy | — | $169.12 | $170.00 | +0.5% | +2.3% | +5.1% | +1.9% | +1.0% | +2.0% |
| Nov 6 | Wells Fargo | Maintains | Overweight → Overweight | — | $151.56 | $173.90 | +14.7% | +10.6% | +6.5% | +7.2% | +6.6% | +6.1% |
| Nov 6 | Piper Sandler | Maintains | Overweight → Overweight | — | $151.56 | $173.90 | +14.7% | +10.6% | +6.5% | +7.2% | +6.6% | +6.1% |
| Nov 6 | Raymond James | Upgrade | Market Perform → Outperform | — | $151.56 | $173.90 | +14.7% | +10.6% | +6.5% | +7.2% | +6.6% | +6.1% |
| Oct 14 | BTIG | Maintains | Buy → Buy | — | $140.62 | $141.55 | +0.7% | +2.7% | +2.4% | +2.8% | +1.7% | +2.9% |
| Aug 7 | Piper Sandler | Maintains | Overweight → Overweight | — | $110.32 | $118.57 | +7.5% | +11.3% | +16.0% | +15.0% | +15.8% | +16.4% |
| Jun 3 | Piper Sandler | Upgrade | Neutral → Overweight | — | $124.50 | $125.53 | +0.8% | +3.0% | +4.4% | +0.1% | +0.2% | +0.8% |
| May 8 | Piper Sandler | Maintains | Neutral → Neutral | — | $136.00 | $130.00 | -4.4% | -11.8% | -8.7% | -10.5% | -14.6% | -15.3% |
| Apr 15 | Stifel | Upgrade | Hold → Buy | — | $137.92 | $142.14 | +3.1% | +0.1% | +0.2% | -0.9% | -1.5% | -2.3% |
| Mar 25 | Wells Fargo | Upgrade | Equal Weight → Overweight | — | $134.93 | $153.76 | +14.0% | +3.3% | +4.2% | +7.1% | +8.8% | +7.3% |
| Mar 25 | BTIG | Maintains | Buy → Buy | — | $134.93 | $153.76 | +14.0% | +3.3% | +4.2% | +7.1% | +8.8% | +7.3% |
| Mar 25 | Stifel | Maintains | Hold → Hold | — | $134.93 | $153.76 | +14.0% | +3.3% | +4.2% | +7.1% | +8.8% | +7.3% |
| Feb 26 | Piper Sandler | Maintains | Neutral → Neutral | — | $132.21 | $132.21 | +0.0% | -1.1% | -1.6% | -2.7% | -2.8% | -4.3% |
| Jan 30 | Jefferies | Downgrade | Buy → Hold | — | $130.25 | $128.56 | -1.3% | -1.0% | -1.0% | +2.4% | +3.2% | +2.2% |
| Jan 3 | Needham | Downgrade | Buy → Hold | — | $114.61 | $112.54 | -1.8% | -4.7% | -4.0% | -2.6% | -0.1% | -1.0% |
| Nov 8 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $80.60 | $78.20 | -3.0% | +3.7% | +5.3% | +7.9% | +9.5% | +10.6% |
| Nov 8 | Raymond James | Downgrade | Outperform → Market Perform | — | $80.60 | $78.20 | -3.0% | +3.7% | +5.3% | +7.9% | +9.5% | +10.6% |
| Nov 8 | Needham | Maintains | Buy → Buy | — | $80.60 | $78.20 | -3.0% | +3.7% | +5.3% | +7.9% | +9.5% | +10.6% |
| Aug 10 | Raymond James | Maintains | Outperform → Outperform | — | $117.96 | $118.68 | +0.6% | -3.2% | -3.7% | -4.3% | -6.1% | -7.6% |
| Aug 9 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $120.00 | $118.00 | -1.7% | -1.7% | -4.9% | -5.3% | -6.0% | -7.7% |
| Aug 9 | Needham | Maintains | Buy → Buy | — | $120.00 | $118.00 | -1.7% | -1.7% | -4.9% | -5.3% | -6.0% | -7.7% |
| Jul 18 | Stifel | Downgrade | Buy → Hold | — | $147.16 | $107.00 | -27.3% | -20.0% | -23.7% | -23.9% | -22.3% | -23.4% |
| Jul 18 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $147.16 | $107.00 | -27.3% | -20.0% | -23.7% | -23.9% | -22.3% | -23.4% |
| Jul 18 | Needham | Maintains | Buy → Buy | — | $147.16 | $107.00 | -27.3% | -20.0% | -23.7% | -23.9% | -22.3% | -23.4% |
| Jul 10 | Needham | Maintains | Buy → Buy | — | $158.61 | $159.04 | +0.3% | +0.6% | -2.4% | -7.7% | -7.1% | -5.7% |
| Jun 7 | Needham | Maintains | Buy → Buy | — | $166.18 | $166.10 | -0.0% | -1.2% | -5.3% | -5.9% | -5.6% | -3.7% |
| Apr 17 | BTIG | Maintains | Buy → Buy | — | $191.67 | $192.45 | +0.4% | +0.3% | +0.2% | +2.5% | +2.1% | +2.3% |
| Mar 1 | Raymond James | Maintains | Outperform → Outperform | — | $167.31 | $180.87 | +8.1% | +5.2% | +7.5% | +9.0% | +8.2% | +5.8% |
| Mar 1 | Piper Sandler | Maintains | Neutral → Neutral | — | $167.31 | $180.87 | +8.1% | +5.2% | +7.5% | +9.0% | +8.2% | +5.8% |
No insider trades available.
8-K · 7.01
! Medium
Masimo Corporation -- 8-K 7.01: Regulation FD Disclosure
Masimo disclosed material information via press release that investors should review in Exhibit 99.1 for details on developments affecting the company and its parent Danaher.
May 4
8-K
Masimo Corporation -- 8-K Filing
Masimo faces three stockholder lawsuits challenging its merger with Danaher, filed after the definitive proxy statement was disclosed, potentially delaying or jeopardizing the transaction's completion.
Apr 23
8-K
Danaher Corporation -- 8-K Filing
Danaher reported Q1 2026 results from continuing operations, with year-over-year comparisons providing investors insight into the conglomerate's operational performance across its diversified portfolio.
Apr 21
8-K · 1.01
!!! Very High
Masimo Corporation -- 8-K 1.01: Merger Agreement
Danaher Corporation agreed to acquire Masimo Corporation, expanding Danaher's portfolio of patient monitoring and diagnostic devices through this significant healthcare technology consolidation.
Feb 17
8-K · 5.02
!!! Very High
Danaher Corporation -- 8-K 5.02: Executive Change
Danaher's appointment of a new executive signals potential strategic shifts in operations and governance; investors should monitor announcements regarding leadership responsibilities and company direction.
Feb 17
Data updated apr 25, 2026 8:35pm
· Source: massive.com